Terms: = Lymphoma AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Prognosis
493 results:
1. [Expression of MCP-1 and CCR2 in Newly Diagnosed Diffuse Large B-Cell lymphoma and Clinical Significance].
Wang M; Zhang PP; Zhu Q; Hu ZL; Bai X; Wu YP; Li JJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):112-119. PubMed ID: 38387908
[TBL] [Abstract] [Full Text] [Related]
2. MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective study.
Pagani C; Rusconi C; Dalla Pria A; Ravano E; Schommers P; Bastos-Oreiro M; Verga L; Gini G; Spina M; Arcaini L; Steffanoni S; Dalu D; Crucitti L; Lorenzi L; Balzarini P; Cattaneo C; Bongiovanni L; Rosenwald A; Facchetti F; Bower M; Ferreri AJM; Rossi G; Tucci A; Re A
Blood Adv; 2024 Feb; 8(4):968-977. PubMed ID: 38207206
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical study of mature B-cell lymphoma in 11 children with chromosome 11 long-arm abnormalities].
Zhang N; Duan YL; Zhou CJ; Jin L; Yang J; Huang S; Zhang M; Li N
Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):924-929. PubMed ID: 38185522
[No Abstract] [Full Text] [Related]
4. A rare case of fluid overload-associated large B-cell lymphoma and antigen loss at relapse.
Yan X; Chen B; Jing H; Yang Z; Zhang T; Lin Y; Shi J
J Hematop; 2023 Dec; 16(4):235-240. PubMed ID: 38175437
[TBL] [Abstract] [Full Text] [Related]
5. Selectively targeting bcl6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer.
Wu M; Xie J; Xing Y; Zhang L; Chen H; Tang B; Zhou M; Lv S; Huang D; Jian S; Zhou C; Liu M; Guo W; Chen Y; Yi Z
Int J Biol Sci; 2024; 20(2):486-501. PubMed ID: 38169532
[TBL] [Abstract] [Full Text] [Related]
6. [Analysis of 9 cases of pediatric-type follicular lymphoma].
Li GP; Zhang D; Wang YQ; Li ZY; Yuan FF; Li MH; Wang L; Du JW; Zhang LN; Li YF; Wei XD; Fu YW
Zhonghua Er Ke Za Zhi; 2023 Dec; 61(12):1129-1132. PubMed ID: 38018051
[No Abstract] [Full Text] [Related]
7. Primary bone diffuse large B-cell lymphoma (PB-DLBCL): a distinct extranodal lymphoma of germinal centre origin, with a common EZB-like mutational profile and good prognosis.
Ivanova VS; Davies J; Menter T; Wild D; Müller A; Krasniqi F; Stenner F; Papachristofilou A; Dirnhofer S; Tzankov A
Histopathology; 2024 Feb; 84(3):525-538. PubMed ID: 37965677
[TBL] [Abstract] [Full Text] [Related]
8. [Clinical pathological characteristics analysis of ocular adnexal follicular lymphoma].
Li J; Wang YC; Lin JY
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):930-936. PubMed ID: 37936361
[No Abstract] [Full Text] [Related]
9. Single-cell RNA sequencing in double-hit lymphoma: IMPDH2 induces the progression of lymphoma by activating the PI3K/AKT/mTOR signaling pathway.
Gao G; Xue Q; He J; Wu M; Jiang Y; Li Q; Zhang Y; Shi W
Int Immunopharmacol; 2023 Dec; 125(Pt A):111125. PubMed ID: 37907047
[TBL] [Abstract] [Full Text] [Related]
10. Alternative genetic alterations of MYC, BCL2, and/or bcl6 in high-grade B-cell lymphoma (HGBL) and diffuse large B-cell lymphoma (DLBCL): Can we identify different prognostic subgroups?
Blomme S; De Paepe P; Devos H; Emmerechts J; Snauwaert S; Cauwelier B
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23211. PubMed ID: 37897298
[TBL] [Abstract] [Full Text] [Related]
11. Risk of cardiovascular disease in cancer survivors: A cohort study of 446,384 New Zealand primary care patients.
Tawfiq E; Pylypchuk R; Elwood JM; McKeage M; Wells S; Selak V
Cancer Med; 2023 Oct; 12(19):20081-20093. PubMed ID: 37746882
[TBL] [Abstract] [Full Text] [Related]
12. Genomic Profiling of Primary Diffuse Large B-Cell lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets.
Agostinelli C; Morandi L; Righi S; Cirillo L; Iommi M; Tonon C; Mazzatenta D; Zoli M; Rossi M; Bagnato G; Broccoli A; Lodi R; Zinzani PL; Sabattini E; Giannini C; Asioli S
Mod Pathol; 2023 Dec; 36(12):100323. PubMed ID: 37678673
[TBL] [Abstract] [Full Text] [Related]
13. Higher 13-Gene-Estimated TMB Detected from Plasma ctDNA is Associated with Worse Outcome for T-Cell lymphoma Patients.
Chen C; Huang L; Chen Z; Ou Q; Liu S; Jiang X; Chen F; Wei X; Guo H; Shao Y; Zeng C; Li Y; Li W
Adv Biol (Weinh); 2023 Dec; 7(12):e2300042. PubMed ID: 37658484
[TBL] [Abstract] [Full Text] [Related]
14. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
[TBL] [Abstract] [Full Text] [Related]
15. The pathobiology of follicular lymphoma.
Carreras J
J Clin Exp Hematop; 2023 Sep; 63(3):152-163. PubMed ID: 37518274
[TBL] [Abstract] [Full Text] [Related]
16. HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy.
Wan X; Young KH; Bai O
Front Immunol; 2023; 14():1216610. PubMed ID: 37483605
[TBL] [Abstract] [Full Text] [Related]
17. [Establishment and Clinical Significance of Prognostic Nomogram Model for Diffuse Large B-Cell lymphoma Based on Immunohistochemistry Markers and International Prognostic Index Scores].
Xu YW; Zhou YL; Kong FC; Chen ZW; Li F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):753-761. PubMed ID: 37356936
[TBL] [Abstract] [Full Text] [Related]
18. [Clinicopathological features of fibrin-associated diffuse large B-cell lymphoma: a report of six cases].
Sun L; Li P; Zhou XG; Teng XJ; Zheng YY; Zhang YL; Xie JL
Zhonghua Bing Li Xue Za Zhi; 2023 Jun; 52(6):592-598. PubMed ID: 37263924
[No Abstract] [Full Text] [Related]
19. Identification of a novel model based on ferroptosis-related genes for predicting the prognosis of diffuse large B-cell lymphomas.
Wang J; Peng H; Zhang G; Yan W
Hematology; 2023 Dec; 28(1):2198862. PubMed ID: 37199349
[TBL] [Abstract] [Full Text] [Related]
20. High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study.
Zayac AS; Landsburg DJ; Hughes ME; Bock AM; Nowakowski GS; Ayers EC; Girton M; Hu M; Beckman AK; Li S; Medeiros LJ; Chang JE; Stepanovic A; Kurt H; Sandoval-Sus J; Ansari-Lari MA; Kothari SK; Kress A; Xu ML; Torka P; Sundaram S; Smith SD; Naresh KN; Karimi YH; Epperla N; Bond DA; Farooq U; Saad M; Evens AM; Pandya K; Naik SG; Kamdar M; Haverkos B; Karmali R; Oh TS; Vose JM; Nutsch H; Rubinstein PG; Chaudhry A; Olszewski AJ
Blood Adv; 2023 Nov; 7(21):6381-6394. PubMed ID: 37171397
[TBL] [Abstract] [Full Text] [Related]
[Next]
